VICENTINI, Caterina
 Distribuzione geografica
Continente #
EU - Europa 2.507
NA - Nord America 1.946
AS - Asia 1.509
SA - Sud America 180
AF - Africa 25
OC - Oceania 6
Totale 6.173
Nazione #
US - Stati Uniti d'America 1.902
RU - Federazione Russa 1.035
CN - Cina 620
SG - Singapore 498
GB - Regno Unito 482
IT - Italia 240
DE - Germania 177
BR - Brasile 144
SE - Svezia 140
HK - Hong Kong 134
IE - Irlanda 132
VN - Vietnam 114
FR - Francia 108
FI - Finlandia 81
KR - Corea 28
CA - Canada 24
UA - Ucraina 22
ES - Italia 20
JP - Giappone 19
IN - India 17
BE - Belgio 16
AT - Austria 14
NL - Olanda 14
ID - Indonesia 12
TR - Turchia 12
AR - Argentina 11
MX - Messico 11
BD - Bangladesh 10
MA - Marocco 9
IQ - Iraq 8
PL - Polonia 8
EC - Ecuador 7
AU - Australia 6
IR - Iran 5
UZ - Uzbekistan 5
CL - Cile 4
CO - Colombia 4
CZ - Repubblica Ceca 4
KG - Kirghizistan 4
LT - Lituania 4
TW - Taiwan 4
VE - Venezuela 4
ZA - Sudafrica 4
CR - Costa Rica 3
TG - Togo 3
AL - Albania 2
DZ - Algeria 2
ET - Etiopia 2
HR - Croazia 2
IL - Israele 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PK - Pakistan 2
SA - Arabia Saudita 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
ML - Mali 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PY - Paraguay 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 6.173
Città #
Southend 440
Moscow 357
Chandler 319
Singapore 244
Ashburn 190
Dallas 174
Beijing 141
Hong Kong 134
Dublin 123
Verona 119
Woodbridge 112
Ann Arbor 89
Jacksonville 78
New York 76
Munich 62
Houston 57
Shenyang 47
Los Angeles 41
Lawrence 40
Princeton 40
Jinan 38
Wilmington 34
Ho Chi Minh City 33
Dearborn 32
Nanjing 25
The Dalles 25
Tianjin 25
Hebei 24
Helsinki 23
Redmond 23
Turku 22
Changsha 20
Hanoi 19
Tokyo 19
Columbus 18
Nanchang 18
Ningbo 18
Redondo Beach 18
Zhengzhou 18
São Paulo 17
Brussels 16
Guangzhou 15
Milan 15
Denver 14
Hangzhou 14
Buffalo 13
Sindelfingen 13
Haikou 12
Taiyuan 12
Frankfurt am Main 11
Santa Clara 11
London 10
Seoul 10
Bologna 9
Brooklyn 9
Jiaxing 9
Poplar 9
Rome 9
Seattle 9
Stockholm 9
Vienna 9
Madrid 8
San Francisco 8
Biên Hòa 7
Dong Ket 7
Jakarta 7
Norwalk 7
Taizhou 7
Warsaw 7
Ankara 6
Atlanta 6
Chennai 6
Chicago 6
Kent 6
Mexico City 6
Montreal 6
Orem 6
Redwood City 6
Toronto 6
Washington 6
Falkenstein 5
Fuzhou 5
Haiphong 5
Hải Dương 5
Nuremberg 5
Tashkent 5
Amsterdam 4
Bishkek 4
Council Bluffs 4
Curitiba 4
Guayaquil 4
Johannesburg 4
Lanzhou 4
Trevenzuolo 4
Andover 3
Baghdad 3
Boardman 3
Brno 3
Buenos Aires 3
Charlotte 3
Totale 3.794
Nome #
Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53 258
Whole-genome landscape of pancreatic neuroendocrine tumours 252
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups 194
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 193
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 178
Reporting tumor molecular heterogeneity in histopathological diagnosis 176
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 175
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes 168
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies 168
Neoadjuvant strategies for triple negative breast cancer: 'state-of-the-art' and future perspectives 166
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 163
Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract. 159
Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements 159
Perihilar and distal extrahepatic cholangiocarcinomas show different genetic profiles but share MYC copy gain and TP53 mutation as independent poor prognostic markers 158
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 157
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 155
Comparative Lesions Analysis Through a Targeted Sequencing Approach 155
Lung neuroendocrine tumours: deep sequencing of the four WHO histotypes reveals chromatin remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 154
Preliminary results of PRINCiPe (predictors of resistance to immunotherapy with nivolumab [NIV]) study in advanced pretreated non-small cell lung cancer (APNSCLC), investigating the role of an immune genomic signature (IGS) including JAK2, JAK3, PIAS4, PTPN2, STAT3, IFNAR2 alterations 152
Fhit down-regulation is an early event in pancreatic carcinogenesis 148
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 145
COVID-19 seroprevalence amongst healthcare workers: potential biases in estimating infection prevalence 145
Exosomal miRNA signatures of pancreatic lesions 144
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 142
Loss of FGFR4 promotes the malignant phenotype of PDAC 136
Potential role of RICTOR copy number gain (CNG) as a key biomarker of mTOR activity: A comprehensive preclinical analysis in squamous cell lung cancer (SQLC) models 133
Poorly Cohesive Gastric Cancers Showing the Transcriptomic Hallmarks of Epithelial-Mesenchymal Transition Behave Aggressively 133
A differentially expressed set of micrornas in cerebro-spinal fluid (CSF) can diagnose CNS malignancies 124
Lysosomal lipid switch sensitises to nutrient deprivation and mTOR targeting in pancreatic cancer 123
Molecular characterization of extrahepatic cholangiocarcinoma: perihilar and distal tumours display divergent genomic and transcriptomic profiles 121
Long-term organoid culture of a small intestinal neuroendocrine tumor 114
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 114
Transcribed ultraconserved noncoding RNAs (T-UCR) are involved in Barrett's esophagus carcinogenesis 110
Current role of non-coding RNAs in the clinical setting 107
MicroRNA-224 promotes tumor progression in nonsmall cell lung cancer 105
Modulation of Biliary Cancer Chemo-Resistance Through MicroRNA-Mediated Rewiring of the Expansion of CD133+ Cells 105
MicroRNA-224 is implicated in lung cancer pathogenesis through targeting caspase-3 and caspase-7 102
Unmasking the impact of Rictor in cancer: novel insights of mTORC2 complex 97
Wnt signalling modulates transcribed-ultraconserved regions in hepatobiliary cancers 96
Lamc2 Regulates Key Transcriptional and Targetable Effectors to Support Pancreatic Cancer Growth 95
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer 85
MCL1 as putative target in pancreatoblastoma 84
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 82
miR-15b/16-2 deletion promotes B-cell malignancies 77
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 54
Totale 6.261
Categoria #
all - tutte 21.978
article - articoli 20.434
book - libri 0
conference - conferenze 1.544
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.956


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021107 0 0 0 0 0 26 6 2 8 11 32 22
2021/2022424 31 136 8 38 10 7 5 28 28 7 36 90
2022/2023849 44 117 70 138 83 196 15 45 101 11 10 19
2023/2024406 18 25 39 29 57 88 19 31 5 27 52 16
2024/2025977 52 45 45 160 39 43 50 33 140 49 106 215
2025/20262.130 212 148 205 559 873 133 0 0 0 0 0 0
Totale 6.261